Corrigendum
Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes‐Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D’Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross, Misty R Jenkins
Article Year: 2021
Corrigendum
Article Year: 2021
Corrigendum
Article Year: 2021
Corrigendum
Article Year: 2021
Corrigendum
Article Year: 2021
Corrigendum
Article Year: 2021
Corrigendum
Article Year: 2021
Corrigendum
Article Year: 2021
The Need for Digital Health Solutions in Deep Brain Stimulation for Parkinson's Disease in the Time of COVID‐19 and Beyond
Article Year: 2021
CORRIGENDUM
Article Year: 2021
Corrigendum to: Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population‐based testing program
Article Year: 2021
CORRIGENDUM
Article Year: 2021
CORRIGENDUM
Article Year: 2021
Corrigendum
Article Year: 2020
CORRIGENDUM
Article Year: 2021
Corrigendum
Article Year: 2021
CORRIGENDUM
Article Year: 2021
CB1 receptor blockade counters age‐induced insulin resistance and metabolic dysfunction
Article Year: 2021
Corrigendum: MR‐guided 125I seed implantation treatment for maxillofacial malignant tumor
Ying Wang, Peng Kang, Wei He, Rui Li
Article Year: 2021
Corrigendum
Article Year: 2021